(Q40846304)

24 September 2017

1 reference

title

Nephropathy and hypertension in diabetes (English)

1 reference

24 September 2017

Marks JB

1

1 reference

24 September 2017

Raskin P

series ordinal

2

1 reference

24 September 2017

publication date

1 July 1998

1 reference

Medical Clinics of North America

24 September 2017

published in

1 reference

24 September 2017

volume

82

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

877-907

1 reference

Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Long-term effects of the angiotensin converting enzyme inhibitor captopril on metabolic control in non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The predictive value of microalbuminuria in IDDM. A five-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Microalbuminuria in patients with NIDDM: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men. Relationship to changes in skeletal muscle blood flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Relationship between insulin sensitivity, hyperinsulinemia, and insulin-mediated sympathetic activation in normotensive and hypertensive subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Renal effects of nicardipine, a calcium antagonist, in hypertensive type 2 (non-insulin-dependent) diabetic patients with and without nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Acute sodium loading in patients with uncomplicated diabetes mellitus: renal and hormonal effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Glycemic control and prognosis in type I diabetic patients with microalbuminuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Is diabetic nephropathy an inherited complication?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Renal effects of angiotensin II receptor blockade in normotensive subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Reduced albuminuria after dietary protein restriction in insulin-dependent diabetic patients with clinical nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Microalbuminuria. Implications for micro- and macrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Resource utilization and costs of care in the diabetes control and complications trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The benefits of ACE inhibitors and calcium antagonists in slowing progressive renal failure: focus on fixed-dose combination antihypertensive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The effect of dietary protein restriction on the progression of diabetic nephropathy. A 12-month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Erythrocyte sodium-lithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropathy in NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The cost to health plans of poor glycemic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Oxidative stress and diabetic vascular complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effects of insulin on renal sodium excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Nephropathy in NIDDM is associated with cellular markers for hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Diabetic nephropathy. Metabolic versus hemodynamic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Microalbuminuria predicts mortality in non-insulin-dependent diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Relationship of progressively increasing albuminuria to apoprotein(a) and blood pressure in type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

A clinical and histologic study of diabetic nephropathy in the Pima Indians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Autocrine secretion of transforming growth factor-beta in cultured rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Hyperglycemia and microvascular and macrovascular disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The changing natural history of nephropathy in type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Essential hypertension is associated with decreased insulin clearance and insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Increased endothelial albumin permeability mediated by protein kinase C activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Renal function in long-duration type I diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Changes in glucose, insulin, lipid, lipoprotein, and apoprotein concentrations and insulin action in doxazosin-treated patients with hypertension. Comparison between nondiabetic individuals and patients with non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The Natural Course of Microalbuminuria in Insulin‐dependent Diabetes: A 10‐year Prospective Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

How to protect the kidney in diabetic patients: with special reference to IDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Microalbuminuria as a predictor of clinical diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Prevention of diabetic renal disease with special reference to microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Functional and morphological renal manifestations in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Abnormal Na+/H+ antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Initiation and progression of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Insulin resistance in non-insulin-dependent diabetes mellitus is associated with microalbuminuria independently of ambulatory blood pressure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Insulin resistance is a characteristic feature of primary hypertension independent of obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effect of protein intake on glycaemic control and renal function in type 2 (non-insulin-dependent) diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Clinical evaluation of a test for immediate and quantitative determination of urinary albumin-to-creatinine ratio. A brief report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Ionic basis of hypertension in diabetes mellitus. Role of hyperglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Diabetic nephropathy in type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Determinants of progression of microalbuminuria in adolescents with IDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Racial differences in the relation between blood pressure and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effect of low-protein, very-low-phosphorus diet on diabetic renal insufficiency with proteinuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Hypertension in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effect of captopril on heavy proteinuria in azotemic diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Diabetes and hypertension. Blood pressure in clinical diabetic patients and a control population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The predictive value of albuminuria for cardiovascular and renal disease. A 5-year follow-up study of 476 patients with type I diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Raised arterial pressure in parents of proteinuric insulin dependent diabetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Protein glycation in the kidney: role in diabetes and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The world health organization multinational study of vascular disease in diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Central role of sodium in hypertension in diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Microalbuminuria: a genetic link between diabetes and cardiovascular disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

The extracellular matrix in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970028-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70028-6

1 reference

24 September 2017

1 reference